Bio-Path Holdings Inc (BPTH)
1.86
-0.08
(-4.12%)
USD |
NASDAQ |
Jul 02, 16:00
1.81
-0.05
(-2.69%)
After-Hours: 20:00
Bio-Path Holdings SG&A Expense (TTM): 4.339M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 4.339M |
December 31, 2023 | 4.235M |
September 30, 2023 | 4.601M |
June 30, 2023 | 4.81M |
March 31, 2023 | 4.778M |
December 31, 2022 | 4.736M |
September 30, 2022 | 4.822M |
June 30, 2022 | 4.717M |
March 31, 2022 | 4.607M |
December 31, 2021 | 4.533M |
September 30, 2021 | 4.335M |
June 30, 2021 | 4.217M |
March 31, 2021 | 4.181M |
December 31, 2020 | 4.33M |
September 30, 2020 | 4.443M |
June 30, 2020 | 4.369M |
March 31, 2020 | 4.322M |
December 31, 2019 | 4.108M |
September 30, 2019 | 3.784M |
June 30, 2019 | 3.628M |
March 31, 2019 | 3.514M |
December 31, 2018 | 3.379M |
September 30, 2018 | 3.095M |
June 30, 2018 | 3.297M |
March 31, 2018 | 3.29M |
Date | Value |
---|---|
December 31, 2017 | 3.273M |
September 30, 2017 | 3.484M |
June 30, 2017 | 3.223M |
March 31, 2017 | 3.135M |
December 31, 2016 | 3.014M |
September 30, 2016 | 2.879M |
June 30, 2016 | 2.718M |
March 31, 2016 | 2.56M |
December 31, 2015 | 2.497M |
September 30, 2015 | 2.771M |
June 30, 2015 | 2.965M |
March 31, 2015 | 3.120M |
December 31, 2014 | 2.715M |
September 30, 2014 | 2.193M |
June 30, 2014 | 2.290M |
March 31, 2014 | 1.776M |
December 31, 2013 | 1.635M |
September 30, 2013 | 1.547M |
June 30, 2013 | 0.983M |
March 31, 2013 | 0.9946M |
December 31, 2012 | 0.9861M |
September 30, 2012 | 0.9522M |
June 30, 2012 | 1.034M |
March 31, 2012 | 1.106M |
December 31, 2011 | 1.225M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
3.784M
Minimum
Sep 2019
4.822M
Maximum
Sep 2022
4.435M
Average
4.369M
Median
Jun 2020
SG&A Expense (TTM) Benchmarks
Microbot Medical Inc | 4.23M |
INVO Bioscience Inc | 6.596M |
Perspective Therapeutics Inc | 19.11M |
Palatin Technologies Inc | 13.34M |
Actinium Pharmaceuticals Inc | 12.56M |